One repeatedly hears about the one sector where India is still years ahead of China- pharmaceuticals. Well that's true - for now. But what's worrying is that in many people's opinion the country's lead is more a result of China's weaknesses than it is of India's strengths. For instance, the Chinese don't understand US and European regulatory processes as well … Continue reading In pharma, India ahead of China – but for how long?
At a recent press conference to announce the launch of its vaccine Prevenar 13, Pfizer MD Kewal Handa declined to share revenue numbers of the vaccine's predecessor Prevenar in India. That's not surprising - companies rarely reveal internal numbers for specific products. But what was surprising is that it did not provide ORG-IMS numbers either. The … Continue reading No Indian data on vaccines market?